Kestra Medical Technologies (KMTS) schedules 4,117-share common stock sale via Merrill Lynch

Rhea-AI Filing Summary

Kestra Medical Technologies, Ltd. has a proposed sale of 4,117 shares of its common stock through Merrill Lynch on NASDAQ, dated 07/30/2026. The shares relate to performance share unit awards that vested on 07/17/2026 and were granted under the issuer’s equity compensation plan.

Key Figures

Shares proposed for sale: 4,117 shares Associated amount: $93,758.64 Proposed sale date: 07/30/2026 +2 more

5 metrics

Shares proposed for sale 4,117 shares Common stock in securities information section

Associated amount $93,758.64 Amount listed with 4,117 common shares

Proposed sale date 07/30/2026 Date in securities information for shares to be sold

Vesting date of awards 07/17/2026 Vesting of performance share unit awards

Shares from vested awards 4,117 shares Performance share unit awards under equity compensation plan

Key Terms

Form 144, performance share unit awards, equity compensation plan

3 terms

Form 144 regulatory

"144: Securities Information Common Stock"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

performance share unit awards financial

"Vesting of performance share unit awards"

equity compensation plan financial

"Granted as part of issuer equity compensation plan"

A plan by which a company gives employees, directors or contractors ownership or the right to buy ownership in the company through stock, options or similar awards — think of promising slices of the company pie as part of someone's pay. It matters to investors because these awards can change the number of shares outstanding, affect reported profits and influence management’s decisions; large or generous plans can dilute existing holders and alter incentives over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 04:40 PM Accepted by SEC EDGAR 07/30/2026 - 04:39 PM Learn about SEC filing dates

FAQ

What does Kestra Medical Technologies (KMTS) report in this Form 144 filing?

Kestra Medical Technologies reports a proposed sale of 4,117 common shares to be transacted through Merrill Lynch on NASDAQ, related to vested performance share unit awards granted under the company’s equity compensation plan.

How many KMTS shares are proposed to be sold and at what total amount?

The notice covers 4,117 shares of KMTS common stock with an associated amount of $93,758.64. These figures reflect the securities information disclosed for the proposed transaction on NASDAQ.

When are the KMTS shares expected to be sold under this notice?

The proposed transaction date is 07/30/2026. This date appears in the securities information section for the common stock to be sold through Merrill Lynch on NASDAQ.

What is the origin of the KMTS shares listed in this Form 144?

The 4,117 shares originate from the vesting of performance share unit awards on 07/17/2026. These awards were granted as part of Kestra Medical Technologies’ equity compensation plan.

Which broker and exchange are involved in the KMTS stock sale notice?

The securities information lists Merrill Lynch, located at 225 Liberty Street, New York, as the broker, and NASDAQ as the exchange for the proposed sale of Kestra Medical Technologies common stock.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	4117	93758.64	58602497	07/30/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/17/2026	Vesting of performance share unit awards	KESTRA MEDICAL TECHNOLOGIES, LTD.			4117	07/17/2026	Granted as part of issuer equity compensation plan

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)